Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma

pharmanewsdaily- July 8, 2019 0

Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug Zelnorm (tegaserod), a prescription treatment for irritable ... Read More